Evidence map›Paper›PMID 35257100›Full record

ArticleJACC. Case reports2022

Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation.

Yevgeniy Brailovsky, Amirali Masoumi, Rachel Bijou, Estefania Oliveros, Gabriel Sayer, Koji Takeda, Nir Uriel

Open access · goldAbstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Pediatric Myocarditis: What Have We Learnt So Far?Journal of cardiovascular development and disease · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yevgeniy BrailovskyDivision of Cardiology, Jefferson Heart Institute, Sidney Kimmel School of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Amirali MasoumiDivision of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
Rachel BijouDivision of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
Estefania OliverosDivision of Cardiology, Temple University Hospital, Philadelphia, Pennsylvania, USA.
Gabriel SayerDivision of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
Koji TakedaDivision of Cardiovascular Surgery, Columbia University Irving Medical Center, New York, New York, USA.
Nir UrielDivision of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
Columbia University Irving Medical Center · USTemple University Hospital · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell myocarditis is a rare cause of cardiogenic shock requiring a high index of suspicion, rapid immunosuppressive therapy, and mechanical circulatory support. We present the case of a patient with giant cell myocarditis who underwent a successful bridge with four different types of mechanical circulatory support devices to heart transplantation. (

Indexed as

acute heart failurecardiac transplantcardiomyopathyECMO, extracorporeal membrane oxygenationGCM, giant cell myocarditisLVAD, left ventricular assist deviceLVEF, left ventricular ejection fractionOHT, orthotopic heart transplantationPA, pulmonary arteryRA, right atriumRV, right ventricle

Identifiers

PMID35257100
PMCPMC8897036
OpenAlexW4214817032

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.